Title:
FLAVONOID COMPOUNDS AND METHODS AND MATERIALS FOR USING FLAVONOID COMPOUNDS TO TREAT FIBROTIC CONDITIONS
Document Type and Number:
WIPO Patent Application WO/2023/244619
Kind Code:
A3
Abstract:
This document relates to flavonoid compounds and methods and materials for using flavonoid compounds to treat one or more fibrotic conditions (e.g., idiopathic pulmonary fibrosis (IPF), non-alcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC), and/or ocular fibrosis). For example, one or more flavonoid compounds having the structure of Formula (I) or Formula (II) can be administered to a mammal (e.g., a human) having one or more fibrotic conditions (e.g., IPF, NASH, PSC, and ocular fibrosis) to treat the mammal.
More Like This:
Inventors:
HAAK ANDREW (US)
O'HARA STEVEN (US)
GUICCIARDI MARIA (US)
HIRSOVA PETRA (US)
LEBRASSEUR NATHAN (US)
SCHAFER MARISSA (US)
O'HARA STEVEN (US)
GUICCIARDI MARIA (US)
HIRSOVA PETRA (US)
LEBRASSEUR NATHAN (US)
SCHAFER MARISSA (US)
Application Number:
PCT/US2023/025221
Publication Date:
January 18, 2024
Filing Date:
June 13, 2023
Export Citation:
Assignee:
MAYO FOUND MEDICAL EDUCATION & RES (US)
International Classes:
A61K31/352; A61P1/16; A61P27/02; A61K45/06
Foreign References:
US20100226931A1 | 2010-09-09 | |||
US20200316066A1 | 2020-10-08 | |||
US20190336492A1 | 2019-11-07 |
Attorney, Agent or Firm:
WILLIS, Margaret, S. et al. (US)
Download PDF: